Evan Lind
- Immunology top 1%
- Immune Cell Function and Interaction 13
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 6
- Immune Response and Inflammation 5
- T-cell and B-cell Immunology 5
- Hematology top 2%
- Acute Myeloid Leukemia Research 6
- Immunology and Allergy top 5%
- Cell Biology top 2%
- Oncology top 5%
- CAR-T cell therapy research 11
-
- MicroRNA in disease regulation 3
- Co-authors
- Randolph J. NoelleSergio A. QuezadaLamis Z. JarvinenPamela S. OhashiHoward T. PetrieSusan E. ProckopAdam J. LambleKathy A. Bennett
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Evan Lind
34 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Immunology 2.0k
- Hematology 388
- Immunology and Allergy 195
- Cell Biology 472
- Oncology 584
Countries citing papers authored by Evan Lind
This map shows the geographic impact of Evan Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Lind more than expected).
Fields of papers citing papers by Evan Lind
This network shows the impact of papers produced by Evan Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Lind. The network helps show where Evan Lind may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evan Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 17 | |
| 5 | 2020 | 17 | |
| 6 | 2020 | 31 | |
| 7 | 2019 | 14 | |
| 8 | 2018 | 0 | |
| 9 | 2018 | 11 | |
| 10 | 2015 | 1 | |
| 11 | 2012 | 30 | |
| 12 | 2010 | 37 | |
| 13 | 2008 | 53 | |
| 14 | 2007 | 8 | |
| 15 | 2006 | 78 | |
| 16 | Mast cells are essential intermediaries in regulatory T-cell tolerancebreakdown → | 2006 | 590 |
| 17 | 2002 | 452 | |
| 18 | 2002 | 116 | |
| 19 | 1999 | 43 | |
| 20 | 1999 | 12 |
About Evan Lind
Evan Lind is a scholar working on Immunology, Hematology, Oncology, Cancer Research and Immunology and Allergy, having authored 36 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers), Acute Myeloid Leukemia Research (6 papers), Immune cells in cancer (6 papers), Immune Response and Inflammation (5 papers), T-cell and B-cell Immunology (5 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Immunology (2.0k citations), Hematology (388 citations), Immunology and Allergy (195 citations), Cell Biology (472 citations) and Oncology (584 citations). Evan Lind has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Randolph J. Noelle, Sergio A. Quezada, Lamis Z. Jarvinen, Pamela S. Ohashi, Howard T. Petrie, Susan E. Prockop, Adam J. Lamble, Kathy A. Bennett, Marella de Bruijn and Nancy A. Speck. Their work appears in journals such as Blood, The Journal of Immunology, Leukemia, The Journal of Experimental Medicine and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.